Sunshine Act in Today’s Pharma Forecast as Mandate takes Effect

New efforts to reveal the ties between doctors and drug firms

Sunshine Act in today's pharma forecast as mandate takes effect
New efforts to reveal the ties between doctors and drug firms

The earnings picture may be cloudy today in the drug business, but sun is shining in from another quarter. Today is the first day of data-gathering for the newly implemented Physician Payments Sunshine Act.

Read : Sunshine Act in today’s pharma forecast as mandate takes effect
by FiercePharma
1 Aug 2013.

Related post: Will the US Sunshine Law help track Ties between Doctors and Drug Companies in America?

Doctors’ Lucrative Industry Ties

Are doctors really immune to gifts and marketing?

Doctors’ Lucrative Industry Ties
Big Pharma and Doctors

New reporting laws show how widespread gifts and payments, sometimes running into hundreds of thousands of dollars, from drug and device firms are to physicians.

Read Doctors’ Lucrative Industry Ties, by Roni Caryn Rabin, TheNewYorkTimes,
13 May 2013

Related posts:

Raise your Hand if you have any Financial Conflicts of Interest in this Decision…

Dan Berger is Cartoonist behind Natural News

This cartoon seeks to portray the scientific fraud that goes on day to day at the FDA as so-called drug safety review panels are convened to declare dangerous drugs as being perfectly safe – @HealthRanger.

Dan Berger is Cartoonist behind Natural News.

Over the last decade or so, the FDA has quietly become an agent of organized scientific fraud designed to promote the profits of drug companies at the expense of public health. One of the ways this is accomplished is by rigging drug review panels with industry “experts” who maintain financial ties to pharmaceutical companies.

Continue reading: Conflicts of Interest
by Mike Adams, the Health Ranger.

All our posts about big pharma, drugs, DrugMoney, the FDA.
See more comics

On Flickr®

Watch the Diaporama, and the health comics album on DES Diethylstilbestrol's photostream on Flickr

If you already have a flickr® account, add us as a contact
Email your photos to des.daughter@gmail.com with a short description and title :-)

Avoidable Costs in U.S. Healthcare: the $200 Billion Opportunity from using Medicines responsibly

Wiser prescription drug use could cut health costs by billions: study

IMS Health Study Identifies $200+ Billion Annual Opportunity from Using Medicines More Responsibly
Wiser prescription drug use could cut health costs by billions: Study

Avoidable costs of more than $200 billion are incurred each year in the U.S. healthcare system as a result of medicines not being used responsibly by patients and healthcare professionals, according to a new study released today by the IMS Institute for Healthcare Informatics. This represents 8% of the United States’ total annual healthcare expenditures and amounts to millions of avoidable hospital admissions, outpatient treatments, pharmaceutical prescriptions and emergency room visits for patients.

Read Wiser prescription drug use could cut health costs by billions: Study, HuffPost Business, By Linda A. Johnson 06/19/13

Read and/or download the full reportAvoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly, IMS Institute for HealthCare Informatics, June 2013

Sources : IMS Health Study Identifies $200+ Billion Annual Opportunity from Using Medicines More Responsibly, IMS Health, June 19, 2013

The Palliative Machine: Medical Monopoly under the Corporation-State

The American medical system is corrupt, ineffective and unnecessarily costly

The Palliative Machine: Medical Monopoly Under the Corporation-State
Direct-to-consumer advertising began in 1981, and really took off in 1995

The American medical system is corrupt, ineffective and unnecessarily costly. These outcomes are due to state violence on behalf of the politically connected elite (namely private insurers, physicians, pharmaceutical and medical device companies). Artificial scarcity, price-gouging, misallocation of research funding and the suppression of alternative (non-patentable) therapies can be ameliorated by revoking state-conferred elite privilege and re-establishing cooperative, mutualized healthcare financing. ”

A must read: The Palliative Machine: Medical Monopoly Under the Corporation-State, by Sebastin A. B., GreenMedInfo, May 25th 2013

New Drugs trail many old ones in Effectiveness against Disease

Fears of a crisis in drug innovation have grown over the years

New drugs trail many old ones in effectiveness against disease
The effectiveness of new drugs has plummeted since the 1970s

Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. ”

Read New drugs trail many old ones in effectiveness against disease
by Sharon Begley, June 3, 2013, Reuters

Influence of Pharmaceutical Sales Reps in keeping patented Brands in Doctors’ Minds

Why do doctors prescribe the most costly drugs?

Why do doctors prescribe the most costly drugs?
Did our governments leave the education of our doctors to the pharmaceutical industry?

Selling pharmaceuticals is an extremely competitive business and companies know that they need to put their best face forward. That face is usually a smiling drug representative whose job it is to teach your physician about the newest medicines being produced today.
In Canada the drug industry spends roughly $3 billion per year marketing its products, two-thirds of which goes towards the salaries of the sales reps who visit our physicians regularly, and the drug samples they use to enhance their one-on-one learning sessions
. “

Read Why do doctors prescribe the most costly drugs?
by Alan Cassels, Feb 28, 2012.

Big Pharma and Consumer Manipulations… how the Pharmaceutical Industry turns Profits

Six ways Big Pharma manipulates consumers

Six ways Big Pharma manipulates consumers
Pharma is looking at the elderly as a new market for ADHD drugs

Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones. ‘

  1. Repurposing Ritalin
  2. Male Hormone Replacement
  3. Calling Alcoholics and Addicts Mentally Ill and In Need of Vaccines
  4. Pathologizing Insomnia
  5. ”Selling” Chronic Immune Disorders
  6. Recycling Neurontin

Read 6 ways Big Pharma manipulates consumers
by Martha Rosenberg, Apr 28, 2013

Adult Attention Deficit Hyperactivity Disorder emerging Market… and Big Pharma Strategies

Big Pharma’s newest invention: adult ADHD

Big Pharma’s newest invention: Adult ADHD
Who belongs to this untapped market? You do, of course

There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with symptoms similar to pediatric ADHD such as impulsivity, distractibility and difficulty paying attention, following instructions and meeting deadlines, is the next big thing “.

Read Big Pharma’s newest invention: Adult ADHD
by Martha Rosenberg, Oct 1, 2012

The Association of the British Pharmaceutical Industry revealing how much they paid UK Doctors

Drug companies pay doctors £40m for travel and expenses

Drug companies pay doctors £40m for travel and expensesDrug companies are paying an estimated £40m a year to British doctors in service fees, flights, hotel and other travel expenses, according to the trade body that represents pharmaceutical companies.

Doctors have always denied that taking drug company money influences their judgement in any way about a medicine, but suspicions have lingered.

Read Drug companies pay doctors £40m for travel and expenses
by Sarah Boseley, The Guardian, april 2013.